Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nada Kraguljac Kurtović"'
Autor:
Milena Todorović Balint, Nikola Lemajić, Vladimir Jurišić, Sofija Pantelić, Dejana Stanisavljević, Nada Kraguljac Kurtović, Bela Balint
Publikováno v:
Translational Oncology, Vol 39, Iss , Pp 101811- (2024)
Background: Plerixafor is a bicyclam molecule with the ability to reversibly bind to receptor CXCR-4 thus leading to an increased release of stem cells (SC) into the circulation. This study aims to evaluate the efficacy of G-CSF plus plerixafor versu
Externí odkaz:
https://doaj.org/article/06e3a603bc8147d6bef3a6ae7f75d777
Autor:
Ljubomir Jakovic, Vesna Djordjevic, Nada Kraguljac Kurtovic, Marijana Virijevic, Mirjana Mitrovic, Lazar Trajkovic, Ana Vidovic, Andrija Bogdanovic
Publikováno v:
Medicina, Vol 60, Iss 9, p 1443 (2024)
Background and Objectives: With the advent of novel therapies for nucleophosmin gene (NPM1)-mutated acute myeloid leukemia (AML), there is a growing need for the reliable prediction of NPM1 mutations. This study explored the role of cytomorphological
Externí odkaz:
https://doaj.org/article/2c777d71336f4e6cbe724bead21cb0ed
Autor:
Sandra, Bižić Radulović, Vesna, Đorđević, Jelica, Jovanović, Vesna, Knežević, Nada, Kraguljac-Kurtović, Tijana, Dragović Ivančević, Ljubomir, Jaković, Mirjana, Mitrović, Marijana, Virijević, Ana, Vidović, Nada, Suvajdžić-Vuković, Andrija, Bogdanović
Publikováno v:
Genetics & Applications; 2024 Special Issue, p11-11, 1p
Autor:
Ljubomir Jakovic, Vesna Djordjevic, Nada Kraguljac Kurtovic, Sandra Bizic, Jelica Jovanovic, Vesna Knezevic, Tijana Dragovic, Marijana Virijevic, Zlatko Pravdic, Andrija Bogdanovic
Publikováno v:
HemaSphere, Vol 7, p e28365e6 (2023)
Externí odkaz:
https://doaj.org/article/ef19057350fe40289161e55decdcb8e7
Autor:
Mihailo Dragana, Janić, Cedomir Dimitrije, Brasanac, Jovan Srda, Janković, Bogdan Lidija, Dokmanović, Radmio Nada, Krstovski, Janko Nada, Kraguljac Kurtović
Publikováno v:
Pediatric bloodcancer. 53(6)
Autoimmune lymphoproliferative syndrome (ALPS) is a genetic disorder of the immune system caused by inadequate induction of apoptosis via the Fas pathway, mainly characterized by generalized lymphadenopathy, splenomegaly, and autoimmune cytopenias, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::275c7402d28b0442ac2c5d34a18c1a3f
https://pubmed.ncbi.nlm.nih.gov/19588524
https://pubmed.ncbi.nlm.nih.gov/19588524
Autor:
Biljana Mihaljevic, Mihailo Smiljanic, Darko Antic, Nada Kraguljac Kurtovic, Milena Todorovic Balint
Publikováno v:
Annals of Indian Academy of Neurology, Vol 21, Iss 1, Pp 85-87 (2018)
Externí odkaz:
https://doaj.org/article/66e2d3eea7df4f7cab1894bce1c32569
Autor:
Dragana, Janić Mihailo, Dimitrije, Brašanac Čedomir, Srđa, Janković Jovan, Lidija, Dokmanović Bogdan, Nada, Krstovski Radmio, Nada, Kraguljac Kurtović Janko
Publikováno v:
Pediatric Blood & Cancer; Dec2009, Vol. 53 Issue 6, p1117-1119, 3p
Autor:
Vladan P. Čokić, Olivera Mitrović-Ajtić, Bojana B. Beleslin-Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac-Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes
Externí odkaz:
https://doaj.org/article/4875d06e34dc42e5aa02a133763630c9